Table 3.
Effect of CRP at Discharge on Risk of Death or Readmission, Crude and Adjusted for Each Covariate
| HR (95% CI) for CRP at Discharge >12.3 mg/L | |
|---|---|
| Crude | 2.46 (1.29–4.70) |
| Adjusted for: | |
| Chronic HF | 2.31 (1.21–4.41) |
| Ischemic HF | 2.28 (1.19–4.36) |
| DM | 2.14 (1.11–4.12) |
| Anemia | 2.34 (1.22–4.46) |
| Aspirin use | 2.36 (1.23–4.52) |
| Statin use | 2.49 (1.31–4.76) |
| ACEI or ARB use | 2.49 (1.30–4.76) |
| BNP, per 100 pg/mL | 2.38 (1.24–4.56) |
Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin II receptor blocker; BNP, b‐type natriuretic peptide; CI, confidence interval; CRP, C‐reactive protein; DM, diabetes mellitus; HF, heart failure; HR, hazard ratio